Clinical Scorecard: Intraoperative Decision-Making for Hartmann’s Procedure in Rectal Cancer Surgery: Insights from a Retrospective Multicenter Analysis
At a Glance
Category
Detail
Condition
Rectal cancer requiring surgical resection
Key Mechanisms
Surgical resection options include anterior resection (AR) with total mesorectal excision (TME), abdominoperineal resection (APR), and Hartmann’s procedure (HP); HP involves rectal removal leaving an anorectal stump and is considered when restoration of bowel continuity poses high risk
Target Population
Patients with rectal adenocarcinoma located >5 cm from the anal verge, particularly older patients with comorbidities or high risk of anastomotic leak
Care Setting
Surgical oncology units performing rectal cancer resections, including emergency and elective settings
Key Highlights
HP is recommended for middle and upper rectal tumors where anastomotic leak risk is high or in patients with incontinence history
HP usage varies internationally due to concerns about pelvic sepsis, though recent data suggest lower septic complication rates making HP a reliable alternative
Intraoperative decisions to switch from planned AR to HP occur based on adverse events or patient factors identified during surgery
Guideline-Based Recommendations
Diagnosis
Rectal cancer defined as adenocarcinoma ≤ 15 cm from the anal verge
Tumor location assessment critical to surgical planning, with tumors ≤ 5 cm typically managed by APR
Management
AR with TME is standard for middle and upper rectal tumors
APR recommended for tumors ≤ 5 cm from anal verge per Swedish guidelines
HP considered when anastomotic leak risk is unacceptably high or in patients with incontinence
HP may be chosen intraoperatively due to adverse events or patient comorbidities
Monitoring & Follow-up
Preoperative evaluation includes cardiovascular, pulmonary, diabetic status, immunosuppression, smoking history, and blood tests (albumin, CEA, creatinine)
Intraoperative assessment to decide on procedure modification
Postoperative monitoring for septic complications, especially pelvic sepsis
Risks
Anastomotic leak risk with AR
Pelvic sepsis risk historically associated with HP but recent data show lower rates
Higher complication risk in older patients and those with cardiovascular disease or diabetes
Patient & Prescribing Data
Patients with rectal cancer undergoing surgical resection, particularly those >5 cm from anal verge and with comorbidities
HP performed in 19% of cases, often in older patients with higher ASA scores and comorbidities; intraoperative decisions to switch to HP are based on adverse events or patient risk factors
Clinical Best Practices
Exclude patients with tumors ≤ 5 cm from HP consideration per guidelines
Use multidisciplinary team conferences and outpatient notes to plan surgery
Consider patient comorbidities and intraoperative findings when deciding to perform HP
Maintain high data validity through registries like SCRCR for outcome tracking
Ensure colorectal surgeon involvement for TME technique and complex decision-making
